作者: Mirjam Gerwing , Christine Jacobsen , Sergey Dyshlovoy , Jessica Hauschild , Tina Rohlfing
DOI: 10.1007/S00432-016-2204-6
关键词:
摘要: Background Cisplatin-based chemotherapy is highly effective in metastasized germ cell tumours (GCT). However, 10–30 % of patients develop resistance to cisplatin, requiring salvage therapy. We investigated the vitro activity paclitaxel and novel taxane cabazitaxel cisplatin-sensitive -resistant GCT lines.